🔎 Trials Near Me

Utama › Glioblastoma › Florida › Miami

Kajian klinikal Glioblastoma di Miami, FL

14 kajian untuk Glioblastoma sedang mencari peserta di lokasi dalam dan sekitar Miami (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.

Teks kajian rasmi (Bahasa Inggeris)

Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →

Ruxolitinib With Radiation and Temozolomide Compared to Radiation and Temozolomide for Newly Diagnosed Glioblastoma

Mengambil pesertaFasa 2
  • Baptist Health Herbert Wertheim Cancer Institute, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Okt 2026 · NCT06991101

Testing the Addition of an Anti-cancer Drug, Selinexor, to the Usual Chemotherapy Treatment (Temozolomide) for Brain Tumors That Have Returned After Previous Treatment

Mengambil pesertaFasa 1/2
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT05432804

A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma

Mengambil pesertaFasa 2/3
  • Sylvester Comprehensive Cancer Center*, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 1 Okt 2026 · NCT03970447

Sonocloud-9 in Association With Carboplatin Versus Standard-of-Care Chemotherapies (CCNU or TMZ) in Recurrent GBM

Mengambil pesertaFasa 3
  • Miami Cancer Institute, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Sep 2026 · NCT05902169

Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII

Mengambil pesertaFasa 2
  • Miami Cancer Institute, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Sep 2026 · NCT07326566

Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma

Mengambil pesertaFasa 1
  • University of Miami (Data collection only), Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 9 Sep 2026 · NCT06934889

Targeted Pediatric High-Grade Glioma Therapy

Mengambil pesertaKajian pemerhatian
  • University of Miami, Miami
12 Months – 39 Years · Semua jantina · Dikemas kini 8 Sep 2026 · NCT05839379

Testing the Addition of an Anti-Cancer Drug, Triapine, to the Usual Radiation Therapy for Recurrent Glioblastoma or Astrocytoma

Mengambil pesertaFasa 1
  • University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami
  • UM Sylvester Comprehensive Cancer Center at Kendall, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 2 Sep 2026 · NCT06860594

Study of Olutasidenib and Temozolomide in HGG

Mengambil pesertaFasa 2
  • University of Miami Hospital and Clinics, Miami
Umur 12 hingga 39 · Semua jantina · Dikemas kini 1 Sep 2026 · NCT06161974

SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)

Mengambil pesertaFasa 3
  • University of Miami Health, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 28 Ogo 2026 · NCT05303519

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

Mengambil peserta
  • University of Miami, Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 29 Jul 2026 · NCT05284643

Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue

Mengambil pesertaKajian pemerhatian
  • Miami Cancer Institute at Baptist Health, Inc., Miami
Umur 18 ke atas · Semua jantina · Dikemas kini 4 Feb 2026 · NCT05756985

Treatment of Relapsed/Refractory Intracranial Glioma in Patients Under 22 Years of Age

Mengambil pesertaFasa 1/2Sukarelawan sihat dialu-alukan
  • Jackson Memorial Hospital, Miami
Umur 1 hingga 21 · Semua jantina · Dikemas kini 8 Dis 2025 · NCT05956821

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Mengambil pesertaKajian pemerhatian
  • Massive Bio SYNERGY-AI site, Miami
Semua umur · Semua jantina · Dikemas kini 28 Okt 2025 · NCT03452774

Kajian Glioblastoma di bandar lain

Kajian lain di Miami

Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.